Zhejiang Medicine Co., Ltd. (SHA:600216)
China flag China · Delayed Price · Currency is CNY
13.39
-0.27 (-1.98%)
Apr 28, 2025, 3:00 PM CST

Zhejiang Medicine Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
9,3819,3757,7628,0739,0887,294
Upgrade
Other Revenue
--32.1143.2341.332.53
Upgrade
Revenue
9,3819,3757,7948,1169,1297,327
Upgrade
Revenue Growth (YoY)
16.75%20.29%-3.96%-11.10%24.60%4.02%
Upgrade
Cost of Revenue
5,1745,4075,3925,4385,5304,410
Upgrade
Gross Profit
4,2073,9692,4022,6783,5992,917
Upgrade
Selling, General & Admin
1,6251,6871,4811,3121,5461,537
Upgrade
Research & Development
730.6749.35860.07809.28806.86546.09
Upgrade
Other Operating Expenses
36.9724.5578.4369.8675.1773.04
Upgrade
Operating Expenses
2,3922,4602,4202,1882,4392,140
Upgrade
Operating Income
1,8151,508-18.15489.741,160777.42
Upgrade
Interest Expense
---28.34-33.11-39.54-46.27
Upgrade
Interest & Investment Income
8.08-16.5113.1857.42139.56
Upgrade
Currency Exchange Gain (Loss)
--36.5966.6-64.31-38.46
Upgrade
Other Non Operating Income (Expenses)
40.38-5.5321.09-36.73-2.69-31.87
Upgrade
EBT Excluding Unusual Items
1,8631,50327.7499.671,111800.38
Upgrade
Impairment of Goodwill
---9.23-8.12--
Upgrade
Gain (Loss) on Sale of Investments
-23.28-29.6-28.59-56.5151.7330.48
Upgrade
Gain (Loss) on Sale of Assets
3.043.09323.57-1.37-7.95-23.48
Upgrade
Asset Writedown
-278.16-263.9---46.19-9.85
Upgrade
Other Unusual Items
--49.8257.7144.7653.45
Upgrade
Pretax Income
1,5651,212363.28491.391,154850.98
Upgrade
Income Tax Expense
238.88192.0386.48128.77268.97191.34
Upgrade
Earnings From Continuing Operations
1,3261,020276.79362.61884.56659.64
Upgrade
Minority Interest in Earnings
133.81140.26152.85176.96160.7657.76
Upgrade
Net Income
1,4601,161429.64539.571,045717.4
Upgrade
Net Income to Common
1,4601,161429.64539.571,045717.4
Upgrade
Net Income Growth
242.92%170.11%-20.37%-48.38%45.71%109.29%
Upgrade
Shares Outstanding (Basic)
948959961964959957
Upgrade
Shares Outstanding (Diluted)
948959961964959957
Upgrade
Shares Change (YoY)
-2.03%-0.15%-0.31%0.47%0.26%0.46%
Upgrade
EPS (Basic)
1.541.210.450.561.090.75
Upgrade
EPS (Diluted)
1.541.210.450.561.090.75
Upgrade
EPS Growth
250.03%170.51%-20.13%-48.62%45.33%108.33%
Upgrade
Free Cash Flow
846.32534.15-162.56-455.39197.05721.37
Upgrade
Free Cash Flow Per Share
0.890.56-0.17-0.470.200.75
Upgrade
Dividend Per Share
--0.1500.1700.3300.230
Upgrade
Dividend Growth
---11.77%-48.48%43.48%-77.00%
Upgrade
Gross Margin
44.84%42.33%30.82%33.00%39.43%39.81%
Upgrade
Operating Margin
19.35%16.09%-0.23%6.03%12.71%10.61%
Upgrade
Profit Margin
15.56%12.38%5.51%6.65%11.45%9.79%
Upgrade
Free Cash Flow Margin
9.02%5.70%-2.09%-5.61%2.16%9.84%
Upgrade
EBITDA
2,5532,230640.441,1711,7471,281
Upgrade
EBITDA Margin
27.21%23.79%8.22%14.42%19.14%17.49%
Upgrade
D&A For EBITDA
737.77721.94658.59680.81586.79503.81
Upgrade
EBIT
1,8151,508-18.15489.741,160777.42
Upgrade
EBIT Margin
19.35%16.09%-0.23%6.03%12.71%10.61%
Upgrade
Effective Tax Rate
15.26%15.84%23.81%26.21%23.32%22.48%
Upgrade
Revenue as Reported
--7,7948,1169,1297,327
Upgrade
Advertising Expenses
--21.2519.5921.320.8
Upgrade
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.